Swiss consumer biotech company Timeline (parent company Amazentis) has launched Mitopure Gummies, a new format for its Urolithin A supplement containing a patented and pure form of this postbiotic.

The company said its Mitopure Gummies support cellular health by helping remove damaged mitochondria and waste (mitophagy) and create new, healthy mitochondria, improving the cell’s ability to produce energy, which often translates to the body feeling stronger and more energized.

Timeline’s supplements are backed by more than 15 years of research, five gold standard human clinical trials and more than 100+ granted patents, the company said.

Clinical studies show improved cellular energy at 28 days, with muscle strength increasing by up to 12% after 16 weeks. Additional benefits include supporting the immune system and skin health.

“Timeline is intent on making Mitopure — the most clinically researched longevity supplement on the market — available to as many people as possible because of its extraordinary health benefits,” said Chris Rinsch, PhD, co-founder and president of Timeline.

“We continue to innovate new formats to bring Urolithin A to a broader audience, expanding from powder for smoothies, to capsules and now to gummies, a form that enables more consumers to be consistent in their supplementation,” said Brian Ray, CEO of Timeline.

The strawberry-flavored gummies are vegan, sugar-free, a good source of fiber, and contain 10 calories per two-gummy serving. The product is Clean Label Project and NSF Contents Certified.

The recommended dosage is two gummies daily (500 mg Mitopure per day); each package contains 60 gummies, or a one-month supply. Mitopure Gummies have been shown to deliver bioavailability and absorption comparable to Timeline’s other supplement formats, the company said.

Timeline’s supplements are formulated in Switzerland, manufactured in the U.S., and sold on Timeline.com and on Amazon.